CCMINC
UTHR icon

Cardinal Capital Management Inc (North Carolina)’s United Therapeutics UTHR Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.49M Sell
11,970
-163
-1% -$91.8K 0.78% 43
2026
Q1 		$7.19M Buy
12,133
+37
+0.3% +$18.4K 0.93% 37
2025
Q4 		$5.89M Buy
12,096
+12
+0.1% +$5.59K 0.78% 44
2025
Q3 		$5.07M Buy
12,084
+208
+2% +$70K 0.7% 49
2025
Q2 		$3.41M Buy
11,876
+177
+2% +$52.9K 0.5% 66
2025
Q1 		$3.61M Buy
11,699
+631
+6% +$216K 0.56% 63
2024
Q4 		$3.91M Buy
11,068
+208
+2% +$76.5K 0.61% 58
2024
Q3 		$3.89M Buy
10,860
+621
+6% +$210K 0.61% 57
2024
Q2 		$3.26M Buy
10,239
+284
+3% +$75.2K 0.55% 59
2024
Q1 		$2.29M Buy
9,955
+1,675
+20% +$378K 0.37% 83
2023
Q4 		$1.82M Buy
8,280
+40
+0.5% +$9.22K 0.34% 85
2023
Q3 		$1.86M Buy
8,240
+146
+2% +$33.6K 0.38% 79
2023
Q2 		$1.79M Buy
8,094
+102
+1% +$22.6K 0.36% 82
2023
Q1 		$1.79M Buy
7,992
+4
+0.1% +$986 0.37% 82
2022
Q4 		$2.22M Buy
7,988
+85
+1% +$21.5K 0.47% 69
2022
Q3 		$1.66M Buy
7,903
+109
+1% +$24.4K 0.39% 77
2022
Q2 		$1.84M Buy
7,794
+81
+1% +$16.5K 0.42% 71
2022
Q1 		$1.38M Buy
7,713
+732
+10% +$139K 0.28% 92
2021
Q4 		$1.51M Buy
6,981
+65
+0.9% +$12.8K 0.3% 88
2021
Q3 		$1.28M Buy
6,916
+115
+2% +$22.7K 0.28% 94
2021
Q2 		$1.22M Buy
6,801
+95
+1% +$18.1K 0.26% 102
2021
Q1 		$1.12M Buy
6,706
+110
+2% +$18.3K 0.25% 102
2020
Q4 		$1M Buy
6,596
+308
+5% +$40.4K 0.24% 102
2020
Q3 		$635K Buy
6,288
+364
+6% +$39.9K 0.17% 110
2020
Q2 		$716K Sell
5,924
-840
-12% -$94.5K 0.21% 105
2020
Q1 		$641K Buy
6,764
+842
+14% +$80K 0.21% 108
2019
Q4 		$522K Buy
+5,922
New +$521K 0.14% 123

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s UTHR Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) reduced its United Therapeutics (UTHR) stake by 1.3% in Q2 2026, selling an estimated $91.8K and leaving 11,970 shares worth $6.49M. The position accounts for 0.78% of the portfolio, ranked #43.

Cardinal Capital Management Inc (North Carolina) first reported a position in UTHR in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.19M in Q1 2026. 417 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 11,970 shares of United Therapeutics worth $6.49M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) sold 163 United Therapeutics shares in Q2 2026, an estimated $91.8K.
  • United Therapeutics made up 0.78% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #43 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in United Therapeutics in Q4 2019 and has held it in 27 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s United Therapeutics position peaked at $7.19M in Q1 2026.
  • 417 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.